This course is part of CardiologyNOW: Live July 8-9, 2026.
Generic Placeholder Website Image

Activity content starts in:

Industry Webcast

Redemplo® (plozasiran): A Treatment to Lower Triglycerides for Adults With Familial Chylomicronemia Syndrome (FCS)Industry Webcast Sponsored by Arrowhead Pharmaceuticals; Not for CME/CE Credit

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 7/8/2026

Expiration Date: 1/8/2027

Faculty

Default Biography Avatar

Archna Bajaj, MD

Learn More

Supporters and Partners

Industry Sponsor

Arrowhead Pharmaceuticals

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

Redemplo® (plozasiran): A Treatment to Lower Triglycerides for Adults With Familial Chylomicronemia Syndrome (FCS)

Register